A chemically induced rat model of hemolysis with disseminated thrombosis

Cardiovascular Toxicology

Volumn 2, Issue 3, 2002, Pages 181-193

  Ezov, Nathan ^a   Levin Harrus, Tal ^a   Mittelman, Moshe ^b   Redlich, Meir ^c   Shabat, Shay ^d   Ward, Sandy M ^e   Peddada, Shymal ^e   Nyska, Meir ^d   Yedgar, Saul ^c   Nyska, Abraham ^e  

^a Harlan Biotech Israel Limited   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY   (Israel)

^d MEIR MEDICAL CENTER   (Israel)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

2 Butoxyethanol; Heart; Hemolysis; Infarct; Rat model; Thrombosis

Indexed keywords

2 BUTOXYETHANOL; ETHYLENE GLYCOL DERIVATIVE; N BUTOXYETHANOL; N-BUTOXYETHANOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DISEASE; BRAIN INFARCTION; CELL STRUCTURE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE; EYE DISEASE; FEMALE; GENDER; HEART INFARCTION; HEMOLYTIC ANEMIA; HISTOPATHOLOGY; INTRACARDIAC THROMBOSIS; LUNG EMBOLISM; LUNG INFARCTION; MALE; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; RAT; SICKLE CELL ANEMIA; STATISTICAL SIGNIFICANCE; THALASSEMIA; THROMBOSIS; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; FISCHER 344 RAT; HEMOLYSIS; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; SEX DIFFERENCE; SPLEEN;

ANIMALIA; PURPURA;

ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; ETHYLENE GLYCOLS; FEMALE; HEMOLYSIS; MALE; ORGAN SIZE; RATS; RATS, INBRED F344; SEX FACTORS; SPLEEN; THROMBOSIS;

EID: 0038506233     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:2:3:181     Document Type: Article

References (45)

1. Barker, J.E. and Wandersee, N.J. (1999). Thrombosis in heritable hemolytic disorders. Curr. Opin. Hematol. 6: 71-75.
2. Borgna Pignatti, C., Carnelli V., Caruso, V., et al. (1999). Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol. 99:76-79.
3. Eldor, A., Maclouf, J., Lellouche, F., et al. (1993). A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major. Southeast Asian J. Trop. Med. Public Health 1(24 Suppl.):92-95.
4. Eldor, A., Durst, R., Hy-Am, E., et al. (1999). A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br. J. Haematol. 107:739-746.
5. Logothetis, J., Constantoulakis, M., Economidou, J., et al. (1972). Thalassemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology 22:294-304.
6. Gibson, T. (1984). A market analysis of 2-butoxyethanol and 2-butoxyethylacetate. Prepared for the U.S. Environmental Protection Agency, Regulatory Impact Branch, subcontract EPA 36-5 of ICF, Inc., contract no. 68-02-4055.
7. Ghanayem, B.I., Ward, S.M., Blair, P.C., and Matthews, H.B. (1990). Comparison of the hematologic effects of 2-butoxyethanol using two types of hematology analyzers. Toxicol. Appl. Pharmacol. 106:341-345.
8. Udden, M.M. (2002). In vitro sub-hemolytic effects of butoxyacetic acid on human and rat erythrocytes. Toxicol. Sci. 69:258-264.
9. Udden, M.M. (2000). Rat erythrocyte morphological changes after gavage dosing with 2-butoxyethanol: a comparison with the in vitro effects of butoxyacetic acid on rat and human erythrocytes. J. Appl. Toxicol. 20:381-387.
10. National Toxicology Program. (1998). Toxicology and carcinogenesis studies of 2-butoxyethanol (CAS No. 111-76-2) in F344/N rats and B6C3F1 mice (inhalation studies). Technical Report Series 484, Department of Health and Human Services, Public Health Service, Bethesda, MD.
11. Long, P.H., Maronpot, R.R., Ghanayem, B.I., Roycroft, J.H., and Nyska, A. (2000). Dental pulp infarction in female rats following inhalation exposure to 2-butoxyethanol. Toxicol. Pathol. 28:246-252.
12. Nyska, A., Maronpot, R.R., Long, P.H., et al. (1999). Disseminated thrombosis and bone infarction in female rats following inhalation exposure to 2-butoxyethanol. Toxicol. Pathol. 27:287-294.
13. Nyska, A., Maronpot, R.R., and Ghanayem, B.I. (1999). Ocular thrombosis and retinal degeneration induced in female F344 rats by 2-butoxyethanol. Hum. Exp. Toxicol. 18:577-582.
14. Chanas, B., Ward, S., Healy, R., Nyska, A., and Ghanayem, B.I. (1999). Effect of gender on the hematotoxicity of 2-butoxyethanol (BE) in F344 rats. 38th Annual Meeting of The Society of Toxicology, New Orleans, LA (abstract).
15. Ghanayem, B.I., Long, P.H., Ward, S.M., Chanas, B., Nyska, M., and Nyska, A. (2001). Hemolytic anemia, thrombosis, and infarction in male and female F344 rats following gavage exposure to 2-butoxyethanol. Exp. Toxicol. Pathol. 53:97-105.
16. Ghanayem, B.I. (1996). An overview of the hematotoxicity of ethylene glycol ethers. Occup. Med. 2:253-268.
17. Ward, S., Blair, P.C., and Ghanayem, B.I. (1989). Hematologic effects of 2-butoxyethanol (BE) in vivo and its effect on the morphology of rat erythrocytes. The Toxicologist 9:1155 (abstract).
18. Udden, M.M. and Paton, C.S. (1994). Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2-butoxyethanol: I. Sensitivity in rats and resistance in normal humans. J. Appl. Toxicol. 14:91-96.
19. Grossblatt, N. (ed.) (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
20. Chhabra, R.S., Huff, J.E., Schwetz, B.S., and Selkirk, J. (1990). An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Program. Environ. Health Perspect. 86:313-321.
21. Boorman, G.A., Morgan, K.T., and Uraich, L.C. (1990). Nose, larynx, and trachea, in Pathology of the Fischer Rat (G.A. Boorman, S.L. Eustis, M.R. Elwell, C.A. Montgomery, and W.F. MacKenzie, ed.), pp. 315-337, Academic Press, New York.
22. Peddada, S.D., Prescott, K.E., and Conaway, M. (2001). Tests for order restrictions in binary data. Biometrics 57: 1219-1227.
23. Andrews, C.H., England, M.C., and Kemp, W.B. (1983). Sickle cell anemia: an etiological factor in pulpal necrosis. J. Endodontics 9:249-252.
24. Greves, P. (2000). Haematopoietic and lymphatic system, in Histopathology of Preclinical Studies, Interpretation and Relevance in Drug Safety Evaluation, II Edition (P. Greaves, ed.), pp. 87-156, Elsevier, Amsterdam, Holland.
25. Zbinden, G. and Grimm, L. (1985). Thrombogenic effects of xenobiotics. Arch. Toxicol. Suppl. 8:131-141.
26. Yabuki, M., Tani, N., Yoshioka, T., Nishibe, H., Kanamaru, H., and Kaneko, H. (2000). Local thrombus formation in the site of intravenous injection of chlorpromazine: possible colloid-osmotic lysis of the local endothelial cells. Biol. Pharm. Bull. 23:957-961.
27. Leach, J.W., Pham, T., Diamandidis, D., and George, J.N. (1999). Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): a case report. Am. J. Hematol. 61:268-270.
28. Bonner, H. and Erslev, A.J. (1994). The blood and lymphoid organs, in Pathology, 2nd Edition (E. Rubin and J.L. Farber, ed), pp995-1096, JB Lippincott, Philadelphia, PA.
29. Yokozawa, T., Takako, N., Kunihiko, W., and Koizumi, F. (2001). Animal model of diabetic nephropathy. Exp. Toxicol. Pathol. 53:359-363.
30. Ghanayem, B.I., Blair, P.C., Thompson, H.B., Maronpot, R.R., and Matthews, H.B. (1987). Effect of age on the toxicity and metabolism of ethylene glycol monobutyl ether (2-butoxyethanol) in rats. Toxicol. Appl. Pharmacol. 91: 222-234.
31. Ghanayem, B.I. (1989). Metabolic and cellular basis of 2-butoxyethanol-induced hemolytic anemia in rats and assessment of human risk in vitro. Biochem. Pharmacol. 38:1679-1684.
32. Ghanayem, B.I. and Sullivan, C.A. (1993). Assessment of the hemolytic activity of 2-butoxyethanol and its major metabolite, butoxyacetic acid, in various mammals including humans. Hum. Exp. Toxicol. 12:305-311.
33. Ghanayem, B.I., Burka, L.T., and Matthews, H.B. (1987). Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: role of alcohol and aldehyde dehydrogenases. J. Pharmacol. Exp. Ther. 242:222-231.
34. 1 mice. Technical Report Series Number 26, NIH publication 93-3349, U.S. Department of Health and Human Services, Public Health Service, Bethesda, MD.
35. Udden, M.M. (2000). Rat erythrocyte morphological changes after gavage dosing with 2-butoxyethanol: a comparison with the in vitro effects of butoxyacetic acid on rat and human erythrocytes. J. Appl. Toxicol. 20:381-387.
36. Lock, S.P., Sephton-Smith, R., and Hardisty, R.M. (1961). Stomatocytosis: a hereditary red cell anomaly associated with hemolytic anemia. Br. J. Haematol. 7:303-314.
37. Ghanayem, B.I., Ward, S.M., Chanas, B., and Nyska, A. (2000). Comparison of the acute hematotoxicity of 2-butoxyethanol in male and female F344 rats. Hum. Exp. Toxicol. 19:185-192.
38. Kaysser, T.M., Wandersee, N.J., Bronson, R.T., and Barker, J.E. (1997). Thrombosis and secondary hemochromatosis play major roles in the pathogenesis of jaundiced and spherocytic mice, murine models for hereditary spherocytosis. Blood 90:4610-4619.
39. Hassoun, H., Wang, Y., Vassiliadis, J., et al. (1998). Targeted inactivation of murine band 3 (AE1) gene produces a hypercoagulable state causing widespread thrombosis in vivo. Blood 92:1785-1792.
40. Ryan, T.M., Ciavatta, D.J., and Townes, T.M. (1997). Knockout-transgenic mouse model of sickle cell disease. Science 278:873-876.
41. Eldor, A. and Rachmilewitz, E.A. (2002). The hypercoagulable state in thalassemia. Blood 99: 36-43.
42. Slauson, D.O. (2002). Disturbances of blood flow and circulation, in Mechanisms of Disease, 3rd Edition (D.O. Slauson and B.J. Cooper, ed), pp89-139, Mosby, St. Louis, MO.
43. Sivarao, D.V. and Mehendale, M.H. (1995). 2-Butoxyethanol autoprotection is due to resilience of newly formed erythrocytes to hemolysis. Arch. Toxicol. 69:526-532.
44. Ghanayem, B.I., Sanchez, I.M., and Matthews, H.B. (1992). Development of tolerance to 2-butoxyethanol-induced hemolytic anemia and studies to elucidate the underlying mechanisms. Tox. Appl. Pharmacol. 112:198-206.
45. Kaneko, J.J. (1974). Comparative erythrocyte metabolism. Adv. Vet. Sci. Comp. Med. 18:117-153.